Australia’s Opthea Limited, a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, today announced that recruitment into the Company’s ongoing Phase 2b trial of OPT-302 for wet age-related macular degeneration (AMD)...
At Biopharmadive.com, we read the following excerpt, “Many experts agree that the pharmaceutical drug development industry is on an unsustainable path. Drug development has become slower, more difficult, and more expensive. The average time to market has...
Finland: EHVA starts recruiting participants to clinical trial testing FIT Biotech’s vaccine European EHVA-vaccine alliance (European HIV Vaccine Alliance, EHVA) starts clinical trials including FIT Biotech Oy’s (“Company”, FITBIO: FN...
Martin Slagter for Mlive.com writes: November is Alzheimer’s Disease Awareness Month and a researchers at the University of Michigan are seeking volunteers to help them learn more about early detection of the disease and how it progresses. The clinical trial is...
GlaxoSmithKline plans to carry out clinical trials on its pancreatic drug hopeful, GSK547, following promising results when treating mice and laboratory-grown tumour cells. The experimental drug was found to be effective when paired with Merck & Co’s checkpoint...
Email
Text